Biospecifics Tech Cp (BSTC) |
|
88.53 0 (0%)
|
01-21 01:00 |
|
Open: |
88.47 |
Pre. Close: |
88.53 |
|
High:
|
88.57 |
Low:
|
88.44 |
|
Volume:
|
88,755 |
Market Cap:
|
650M |
|
|
|
|
BioSpecifics Technologies Corp., a biopharmaceutical company, develops an injectable collagenase clostridium histolyticum for various indications in the United States and internationally. The company offers injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease under the XIAFLEX and Xiapex brands. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, plantar fibromatosis, human lipoma, and uterine fibroids. The company has a development and license agreement with Endo Global Ventures. BioSpecifics Technologies Corp. was founded in 1957 and is headquartered in Wilmington, Delaware. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
88.736 - 89.173 |
89.173 - 89.528 |
|
Low:
|
87.291 - 87.9 |
87.9 - 88.395 |
|
Close:
|
87.686 - 88.599 |
88.599 - 89.338 |
|
Technical analysis |
as of: 2021-01-08 4:52:53 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 103.45 One year: 120.83 |
| Support: |
Support1: 88.35  Support2: 88.21 |
| Resistance: |
Resistance1: 88.57 Resistance2: 103.45 |
| Pivot: |
88.50 |
| Moving Average: |
MA(5): 88.53 MA(20): 88.46
MA(100): 71.28 MA(250): 63.42 |
| MACD: |
MACD(12,26): 1.51  Signal(9): 2.11 |
| Stochastic oscillator: |
%K(14,3): 78.40 %D(3): 81.27 |
| RSI: |
RSI(14): 83.00 |
| 52-week: |
High: 89.15 Low: 42.00 Change(%): 53.8 |
| Average Vol(K): |
3-Month: 11398 10-Days: 2168 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.BSTC has closed below upper band by 31.3%. Bollinger Bands are 98.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to BSTC's normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Wed, 18 Mar 2020
Stocks That Hit 52-Week Lows On Wednesday - Benzinga
Sun, 22 Sep 2019
Liberty Global plc - Consenus Indicates Potential -100.0% Downside - DirectorsTalk Interviews
Wed, 31 Dec 1969
Wed, 31 Dec 1969
Wed, 31 Dec 1969
Wed, 31 Dec 1969
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Outperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
|
| Shares Float (M) |
|
|
% Held by Insiders
|
|
|
% Held by Institutions
|
|
|
Shares Short (K)
|
|
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
1.590 |
|
EPS Est Next Year
|
1.690 |
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
5.203 |
|
Sales Per Share
|
4.738 |
|
EBITDA (p.s.)
|
3.153 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
18.68 |
|
Price to Cash Flow
|
|
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
